More recent studies suggested that GNAS mutation might occur in a small subset of gastric adenocarcinomas of the fundic gland type as an alternative mechanism of activating the Wnt/beta-catenin signaling pathway [4]. The gene discussed is CTNNB1; the disease is gastric adenocarcinoma.